| J9271 | Injection, pembrolizumab, 1 mg | 13 | 10 | 90 | $6,340 | $5.2M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 47 | 150 | 5,330 | $50 | $2.8M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 53 | 400 | 1,510 | $190 | $2.6M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 33 | 480 | 1,350 | $110 | $1.7M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 18 | 450 | 1,540 | $90 | $1.3M |
| 96374 | The provider administers a single medication or other substance rapidly into a vein to treat, prevent, or diagnose a condition. | 12 | 150 | 7,610 | $90 | $1.2M |
| G0378 | Hospital observation service, per hour | 7 | 100 | 2,820 | $180 | $1.1M |
| 42820 | The provider removes the tonsils and adenoids in a patient younger than 12 years old. | 18 | 50 | 150 | $1,300 | $889.5K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 59 | 70 | 680 | $100 | $604K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 29 | 160 | 2,720 | $60 | $546.6K |